Jacque Sokolov, MD, president and chairman at SSB Solutions, previews his keynote presentation and discusses the unique, shifting health care atmosphere leading into the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023.
Jacque Sokolov, MD, president and chairman at SSB Solutions, previews his keynote presentation and discusses the unique, shifting health care atmosphere leading into the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023, which runs from April 26-28 in Orlando, FL.
Transcript
What are you most looking forward to at this year’s meeting?
This spring forum in 2023 is arguably one of the most unique forums I think I've ever had the opportunity to keynote. The year is post pandemic, and now we're endemic in terms of COVID-19. The clinical, business, and operational models that are transforming health care have been amplified, and we're all starting to understand how they are affecting everyday life in terms of the health care sectors we deal with.
What are the main drivers of health care market transformation that you’ll be discussing in your keynote presentation?
There'll be 3 areas of transformation that will be focused on. From the clinical transformation area, there could be many, but I'm picking biopharma and AI [artificial intelligence] as the 2 areas that I think are most impactful. From a business transformation perspective, I think it is the super aggregators and the consolidation of certain sectors of the health care economy. And from an operating perspective, I think, quite candidly, it is the appreciation of the workforce burnout and disparity issues that we've seen as a result of COVID-19 and the stress on the US health care system.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen